Neoadjuvant Systemic Therapy Promising for Resectable Colorectal Peritoneal Metastases medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, May 19, 2021 /PRNewswire/ Cancer drugs capable of weakening the body s immune defenses are no more likely to increase the risk of Covid-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows. Researchers say the results challenge initial concerns that such treatments, which poison cancer cells, were too dangerous to continue during the pandemic.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the new investigation involving over 3,000 women treated for breast cancer at the height of the pandemic in New York City showed that only 64, or 2 percent, contracted the virus. Of this group, 10 died from COVID-19, a number the study authors say is low and expected for this age group, regardless of cancer.
Breast Cancer Treatments Do Not Increase Risk of Covid-19 Infection or Death prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Prototype Shows Promise As Approach to Countering Pancreatic Cancer
News provided by
Share this article
Share this article
NEW YORK, May 11, 2021 /PRNewswire/ A research team has designed a molecule with potential to interfere in a new way with altered proteins that cause abnormal growth in 35 percent of pancreatic cancers.
Published online in
Nature Communications on May 11, a new study found that a molecule called a monobody clings to cancer-causing versions of the KRAS protein and keeps them from transmitting their signals. Changes in the DNA of the
KRAS gene – which encodes a molecular switch that toggles between active and inactive states to regulate growth – cause the related protein to become stuck in the on mode. Cells with such mutations continually multiply and give rise to cancer.
Date Time
Case Western Reserve awarded $3 million National Cancer Institute grant to apply AI to immunotherapy
Scientists, medical researchers at Case Western Reserve, NYU Langone Health and University Hospitals using machine-learning to predict response to immunotherapy
Medical researchers from Case Western Reserve University, New York University (NYU), and University Hospitals have been awarded a five-year, $3 million National Cancer Institute grant to develop and apply artificial intelligence (AI) tools for predicting which lung cancer patients will respond to immunotherapy.
A unique aspect of the Case Western Reserve-led study is that it will involve testing of their specific AI tools-for the first time during an ongoing clinical trial.